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Abstract
Objective—Colleges are at risk for communicable disease outbreaks because of the high degree 
of person-to-person interactions and relatively crowded dormitory settings. This report describes 
the U.S. college student health screening requirements among U.S. resident and international 
students for tuberculosis (TB) and vaccine-preventable diseases (VPD) as it relates to the 
American College Health Association (ACHA) Guidelines.
Methods/Participants—In April 2012, U.S. college health administrators (N=2858) were sent 
online surveys to assess their respective school’s TB screening and immunization requirements.
Results—Surveys were completed by 308 (11%) schools. Most schools were aware of the 
ACHA immunization (78%) and TB screening (76%) guidelines. Schools reported having policies 
related to immunization screening (80.4%), immunization compliance (93%), TB screening 
(55%), and TB compliance (87%).
Conclusion—Most colleges were following ACHA guidelines. However, there are opportunities 
for improvement to fully utilize the recommendations and prevent outbreaks of communicable 
diseases among students in colleges.
Background
Applicants for permanent U.S. residency are required by law to have a pre-arrival medical 
evaluation by a physician contracted to the U.S. Department of State [1]. However, no laws 
require temporary visitors, including international students, to have a health screening or 
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obtain vaccinations before arrival. International students may contribute to the burden of TB 
[2] and VPD [3] in the U.S.
Colleges are at risk for communicable disease outbreaks because of the high degree of 
person-to-person interactions (physical contact and exchange of bodily fluids) and relatively 
crowded dormitory settings, according to the Centers for Disease Control and Prevention 
(CDC). [4-6] In the 2012/2013 school year, U.S. colleges and universities enrolled 
approximately 820,000 international students [7], some of which have not taken any health 
related precautions before traveling [8, 9]. A large proportion of incoming international 
students are from China, India and South Korea which have some of the highest incidence 
rates of TB in the world. [7] In the last decade, there have been multiple communicable 
disease outbreaks, including measles [10], mumps [4], pertussis [11] and meningococcal 
[12] among adolescents and college students in the U.S. Vaccine coverage for these 
communicable diseases among adolescents remain low. [13-16].
ACHA publishes recommendations for TB screening [17] and prematriculation 
immunization requirements (PIRs) [18] to help colleges and universities develop 
comprehensive student health policies to mitigate disease transmission [19]. Previous 
evaluations have assessed recommendations for TB screening and PIRs among U.S. colleges 
and universities [20, 21], but these evaluations were conducted more than two decades ago 
and did not include international students. ACHA requested technical assistance from CDC 
to develop a survey to assess student TB screening and immunizations policies and 
procedures at U.S. colleges and universities that enroll international students.
Methods
Participant Identification
In September 2011, we obtained a list of 3808 U.S. colleges and universities (undergraduate, 
graduate, and specialized programs) eligible to enroll international students from the U.S. 
Department of Homeland Security’s Immigration and Customs Enforcement Student and 
Exchange Visitor Program. We categorized schools on the list as ACHA and non-ACHA 
members. We included all member schools and selected a random sample of 1800 
nonmember schools out of 2,742 based on an expected response rate of 20%. We contacted 
nonmember schools by telephone to obtain the name and contact information for a student 
health service or administrative staff member knowledgeable about the school’s student 
health policies.
Survey Tool and Administration
As a collaborative effort between ACHA, CDC and university health subject matter experts, 
a questionnaire was developed to assess the extent to which universities were following 
recommendations for TB screening and prematriculation immunizations. A pre-survey was 
sent to a small sample of universities for piloting and feedback. In April 2012, we e-mailed 
surveys to health center employees or administrators at identified schools and sent reminders 
in May and August. After two reminder e-mails, we contacted nonrespondents by telephone 
to confirm the email address and re-sent the survey to them. The survey instrument was a 
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self-administered, online questionnaire, composed of 44 questions that took approximately 
15-20 minutes to complete. Respondents received a small token of appreciation ($5 gift card 
to a national retail chain). CDC determined that this project was exempt from institutional 
review board approval.
We collected characteristic data of the colleges that included size and type of school; and 
services provided at the school’s health center. College health administrators were asked 
about their awareness of ACHA’s TB and immunization guidelines; the school’s TB 
screening (questionnaire or interview) protocols, TB testing conducted, and TB compliance 
requirements; the school’s immunization and compliance requirements; and any exemptions 
allowed. (Appendix). Screening criteria and vaccinations selected for analysis were based on 
the concern for outbreaks among college campuses and ACHA recommendations for all 
college students. Therefore, the analyses were not comprehensive for all screening, testing, 
or vaccinations available.
Data Analysis
Descriptive analyses were performed on variables included in the survey. We categorized 
schools as following the ACHA guidelines if they indicated having two or more screening 
criteria that were consistent with the 2011 ACHA guidelines. Investigators performed all 
analyses by using SPSS software, version 21 (IBM, Armonk, NY), but did not compare non-
ACHA with ACHA members because of the low response rate of non-ACHA schools.
Results
A total of 308 schools completed the surveys, for an 11% overall response rate. The ACHA 
member response rate was 19% and the nonmember response was 6%. Affiliation with 
ACHA could not be determined for six schools. Student health centers were available in 
85% of the respondent schools. Most respondents considered their schools to be traditional, 
private institutions. Schools with more than 500 international students made up 28% of the 
respondents. Respondent characteristics are summarized in Table 1.
Tuberculosis
Among 263 schools with a health center, 73% offered tuberculin skin test (TST), 32% 
offered interferon-gamma release assay (IGRA), and 22% offered chest radiography in their 
health center. Most respondent schools (76%) were aware of the ACHA TB screening 
guidelines and more than two-thirds (68%) reported having TB screening policies. More 
than half (55%) of schools used a screening questionnaire for all incoming students, as 
recommended by ACHA guidelines. Screening criteria for TB at respondent schools 
included history of active TB, history of a positive TST or IGRA, history of close contact 
with someone who had TB, being born in a country with a high incidence of TB, and history 
of travel to a country that has a high incidence of TB. Of the schools that had TB screening 
policies, 87% also had policies to enforce compliance, such as preventing registration for the 
following semester if the student did not complete screening. Fifteen respondent schools 
reported having screening policies but did not clarify the details of their policies.
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Of the 208 respondent schools with TB screening policies, the proportion of schools that 
screened U.S. resident students and international resident students was similar (47% and 
46%, respectively). However, 46% of schools routinely conducted TB testing for 
international students, and 13% of schools routinely conducted TB testing for U.S. students. 
Eight percent of schools did not conduct TB screening or testing for international students 
and 40% of schools did not conduct testing for U.S. students.
Immunizations
Vaccines offered in the health centers included influenza (74%), tetanus-diphtheria-pertussis 
(Tdap, 65%), hepatitis B (59%), measles-mumps-rubella (MMR, 56%), meningococcal 
(55%), and varicella (37%). Most respondent schools (78%) were aware of the ACHA 
immunization guidelines and 80% of those had an immunization requirement policy. The 
proportion of respondents aware of the ACHA guidelines differed for ACHA members 
(94%) and nonmembers (47%). Of those schools that had requirement policies, 93% had 
compliance policies, such as preventing registration for the following semester (33%), 
preventing registration for current semester (23%), restricting class attendance (16%), 
preventing participation in a clinical healthcare setting course (19%), and preventing 
participation in organized sports (6%). The percentage of respondents that had respective 
state immunization requirements varied by vaccine: MMR (59%); Tdap (56%); 
meningococcal (34%); hepatitis B (28%); and varicella (13%).
Comment
The results of our survey showed that most respondent schools were aware of and following 
the ACHA guidelines. Proportions were higher among ACHA member schools. This is not 
surprising since ACHA would communicate directly with their member schools to provide 
and promote their latest recommendations. However, many schools do not have screening 
and immunization policies and even fewer have compliance policies. Only 59% of 
respondents required student’s to comply with TB screening policies and only 73% of 
respondents required student’s to comply with PIR. Colleges without these policies increase 
the risk for communicable disease transmission. [3, 4, 7]
Most U.S. colleges and universities are mandated by their respective states to immunize their 
incoming students. Thirty-two U.S. states and territories have various vaccine requirements 
for college entry [22, 23]. Typically respondent schools’ policies were more stringent than 
their corresponding state requirements where state requirements existed but less so than the 
ACHA guidelines or Advisory Committee on Immunization Practices (ACIP) [24] 
recommendations. For example, in a state with a mandated requirement for MMR only, one 
of the schools added a requirement for varicella vaccine for all students and meningococcal 
vaccine for students living on campus, but not any of the other ACHA-recommended 
immunizations.
Although TB and some VPDs are not common in the US, international travel increases the 
risk of their importation [25-27]. The international student population is increasing, rising 
7% from the 2011/12 to the 2012/13 school year [7] and poses a potential risk for disease 
importation into the U.S. from endemic countries. For example, it has been estimated that 
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37% of incident TB cases within the U.S. occur among students/exchange visitors and 
temporary workers [2]. College campuses are at risk for communicable disease outbreaks 
due to the large number of students from all over the world, high degree of person-to-person 
interactions, and relatively crowded dormitory settings [4]. China, India, and South Korea, 
the top three countries of origin for international students in the U.S. [7], had estimated TB 
incidence rates of 96, 168, and 90 cases per 100,000 population in 2009, respectively [28]. 
One study estimated that the rate of active TB identified through screening was 32 times 
higher among international students when compared to U.S. students [21].
PIRs for students have been shown to be effective in controlling disease transmission on 
campuses [29, 30]. However, vaccine coverage among adolescents and college students 
remain low. For example, vaccination coverage among adolescents are 74% for mumps (2-
dose) [13], 32% for meningococcal (MCV4) [15], 58% for MMR (3-dose) [14], and 73% for 
pertussis [16].
The increase in international students into the U.S., the lack of medical pre-screening 
evaluation for international students, the low rates of vaccine coverage among adolescents, 
and the limited screening at college entry are potential facilitators for communicable disease 
transmission. Therefore, screening and immunization programs within colleges and 
universities need to be promoted and enforced in order to receive maximum benefits.
Limitations
The results of our survey are subject to several limitations and should be interpreted with 
caution. First, as a result of our low response rate, we were unable to provide generalizable 
estimates or statistically compare results between ACHA and non-ACHA member schools. 
Although the higher response rate for ACHA members was expected, the rate for 
nonmembers was unexpectedly low despite multiple reminders. Anecdotally, a few 
respondents said they did not initially participate because they did not conduct health 
screening. Therefore, the proportion of schools with health screening policies may be 
overestimated. Second, our survey asked specifically about the 2011 guidelines. At the time 
of data collection, ACHA had disseminated its updated recommendations for 2012. Only a 
few respondents replied before the release of the new guidelines and we are unclear as to the 
effect of the new guidelines on our results. Third, our survey did not ask country of origin 
for their international students who attended the schools. Therefore, we were unable to 
assess which schools had a higher risk based on higher endemic levels of TB or other VPD 
of the students’ country of origin. Finally, the survey did not address the differences between 
latent tuberculosis infection (LTBI) and TB disease however ACHA recommendations 
provide guidance to colleges about transmission and treatment for each.
Conclusion
ACHA should be encouraged by the large proportion of schools that follow their TB and 
PIR guidelines. However, our study demonstrates that there are opportunities for 
improvement. Evaluations are needed to explore the facilitators and barriers to implementing 
recommended health policies among colleges and universities, specifically related to 
knowledge, resources, or overall college priorities. At the time this survey was conducted, no 
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states required TB screening or testing for college entry. Since then, at least one state has 
enacted a statute requiring TB screening and targeted testing for all higher education 
students and faculty [31]. Other states might follow this example to promote the health of 
students and prevent the spread of communicable diseases on college campuses. The 
literature suggests that state disease prevention programs, such as state-mandated vaccine 
requirements and screening programs in schools prevent outbreaks of students in colleges 
and universities [29, 32, 33]; national organizations, such as ACHA, that promote such 
programs may increase that effect [19, 34].
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Table 1
Characteristics of U.S. colleges and universities that participated in a 2012 survey of health screening 
requirements







N (%) N (%) N (%)
Campus Size <2500 121 39.5 53 57.0 57 29.5
2500-4999 44 14.4 18 19.4 24 12.4
5000-9999 46 15.0 15 16.1 29 15.0
10000-19999 49 16.0 4 4.3 44 22.8
20000+ 46 15.0 3 3.2 39 20.2
International students <20 41 14.8 23 28.4 16 9.0
20-50 50 12.0 19 16.4 28 15.8
51-160 55 13.2 18 15.5 28 15.8
161-500 55 13.2 19 16.4 35 19.8
501-3000 64 15.4 2 1.7 58 32.8
>3000 12 2.9 0 0.0 12 6.8
Institution Public 139 45.3 35 37.2 96 49.7
Private 168 54.7 59 62.8 97 50.3
Type of School Traditional 226 74.3 52 55.9 163 85.3
Other 78 25.7 41 44.1 28 14.7
Is there on-campus housing? Yes 258 84.0 64 68.8 180 92.8
Degrees offered ** B, M, D 99 32.6 11 11.8 84 43.3
A, B, M, D 11 3.6 0 0.0 11 5.7
B, M only 90 29.6 29 31.2 53 27.3
B only 36 11.8 17 18.3 19 9.8
A only 43 14.1 23 24.7 15 7.7
Graduate only 25 8.2 13 14.0 12 6.2
Aware of ACHA TB Guidelines Yes 233 76.4 41 44.1 180 93.8
Have TB policy Yes 208 67.5 49 52.1 141 72.7
Aware ACHA Immun
¥
 Guidelines Yes 235 76.5 44 46.8 181 93.8
Have Immun
¥
 Policy Yes 243 79.2 62 66.0 166 86.0
*




A - Associate B - Bachelor, M - Master, D - Doctorate
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